Difference between revisions of "MSK Biomarker Ctte"

From QIBA Wiki
Jump to: navigation, search
(Meetings)
 
Line 1: Line 1:
  
:Co-chairs: Thomas M. Link, MD, PhD; Xiaojuan Li, PhD
+
:Co-chairs: Xiaojuan Li, PhD; Thomas M. Link, MD, PhD  
 
:RSNA Staff Support: Susan Stanfa
 
:RSNA Staff Support: Susan Stanfa
* [http://tinyurl.com/QIBA-MSK-Roster Roster]
+
* [https://docs.google.com/spreadsheets/d/e/2PACX-1vTtFdmro0ILLuaCHj65SltPX7AIp2nDeAj4UXWrZGgDTs5WrstIgEr0UTRxY3mSZ6ZnRi6bRuWWHsMt/pubhtml?gid=1066960490&single=true Roster]
  
 
The MSK Biomarker Committee seeks to develop a quantitative Profile for MSK.
 
The MSK Biomarker Committee seeks to develop a quantitative Profile for MSK.

Latest revision as of 17:08, 30 July 2020

Co-chairs: Xiaojuan Li, PhD; Thomas M. Link, MD, PhD
RSNA Staff Support: Susan Stanfa

The MSK Biomarker Committee seeks to develop a quantitative Profile for MSK.

MSK Profile-Wiki Announcement-2.PNG


Meetings

Approved call summaries:

MSK Biomarker Committee Call Summaries Archive

Working Documents

  • QIBA MSK Profile 2020-01-28: MR-based cartilage compositional biomarkers (T1ρ, T2) for risk prediction, early diagnosis and monitoring of treatment of degenerative joint disease

Statistical Reference Documents

Workflow Documents

Reference Materials